๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Crystallization studies of glycosylated and unglycosylated human recombinant interleukin-2

โœ Scribed by Enrico A. Stura; Ping Chen; Carrie M. Wilmot; Jairo H. Arevalo; Ian A. Wilson


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
603 KB
Volume
12
Category
Article
ISSN
0887-3585

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Glycosylated interleukinโ€2 (glyILโ€2) has been crystallized in two crystal forms, and unglycosylated interleukinโ€2 (uILโ€2) has been crystallized in three forms. The glycosylated form of the human recombinant ILโ€2 has been crystallized from 1.9 M ammonium sulfate, pH 6.5 to 7.0 in the hexagonal space group __P__6~2~22 or its enantiomorph. The crystals diffract to 2.8 ร… and contain two or three molecules per asymmetric unit. A second crystal form grows from 1.4 to 1.5 M ammonium sulfate in 0.2 M ammonium acetate, pH 5.0โ€“5.5, as polycrystalline rosettes which are not suitable for even a preliminary crystallographic analysis. The uILโ€2 crystallizes from 1.0 to 1.7 M ammonium sulfate, 0.2 M ammonium acetate, pH 4.5โ€“5.6 in the monoclinic space group __P__2~1~, and less frequently in the orthorhombic space group __P__2~1~2~1~2~1~ from 2.5 M ammonium sulfate, pH 4.5 to 5.7. Crossโ€seeding uILโ€2 with seeds from hexagonal crystals of glyILโ€2 promotes nucleation of trigonal crystals of unglycosylated ILโ€2. These trigonal crystals belong to the space group __P__3~1~21 or its enantiomorph, with similar cell dimensions to the glyILโ€2 hexagonal crystals.


๐Ÿ“œ SIMILAR VOLUMES


Pilot study of recombinant human interle
โœ Shinichi Kakumu; Akihiko Fuji; Kentaro Yoshioka; Hirofumi Tahara; Yoshiyuki Ohta ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 541 KB

Recombinant human interleukin 2 was administered to 10 patients with chronic type B hepatitis as a part of a pilot study to evaluate its antiviral activity. Patients received 1 to 3 x 10' units per day of interleukin 2 for 21 to 28 days, and all completed the treatment schedule. During therapy, seru